PAM
AXDX

PVG Asset Management’s Accelerate Diagnostics AXDX Stock Holding History

PVG Asset Management’s Portfolio AXDX Stock Details AXDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		$164K Hold
1,970
– – 0.39% 49
2019
Q4 		$333K Hold
1,970
– – 0.46% 44
2019
Q3 		$366K Buy
+1,970
New +$381K 0.4% 59

Other funds holding AXDX

OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $214M AUM 185.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Axa
Axa Paris, France $91.9M AUM 27.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GAM
Griffin Asset Management New York $949M AUM 24.98% 1-Year Est. Return
CC
Cannell & Co New York $3.15B AUM 30.62% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return

PVG Asset Management's AXDX Position: Q1 2020 in Review

PVG Asset Management held its Accelerate Diagnostics (AXDX) position steady in Q1 2020 at 1,970 shares worth $164K. The position accounts for 0.39% of the portfolio, ranked #49.

PVG Asset Management first reported a position in AXDX in Q3 2019 and has held it in 3 quarters since. The position peaked at $366K in Q3 2019. 110 funds tracked by Wall St. Rank hold AXDX as of Q1 2020.

  • PVG Asset Management held 1,970 shares of Accelerate Diagnostics worth $164K as of Q1 2020.
  • PVG Asset Management left its Accelerate Diagnostics share count unchanged in Q1 2020.
  • Accelerate Diagnostics made up 0.39% of PVG Asset Management's portfolio in Q1 2020, its #49 holding.
  • PVG Asset Management first reported a position in Accelerate Diagnostics in Q3 2019 and has held it in 3 quarters since.
  • PVG Asset Management's Accelerate Diagnostics position peaked at $366K in Q3 2019.
  • 110 funds tracked by Wall St. Rank held Accelerate Diagnostics as of Q1 2020.

Based on PVG Asset Management's 13F filing for Q1 2020, filed 15 May 2020.